News
CellFE, a leader in non-viral gene editing technology, today announced a strategic collaboration with the Harbottle Lab at ...
What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...
1d
GlobalData on MSNPacira’s gene therapy shows sustained benefits in trial for knee osteoarthritisPacira BioSciences has announced that its gene therapy candidate, PCRX-201 (enekinragene inzadenovec), has demonstrated ...
7h
Onlymyhealth on MSNGene Therapy: Expert Explains How It Can Help Deal With Critical Cases Of HaematologyLearn how gene therapy is revolutionising the treatment of haemophilia a genetic disorder that affects blood clotting ...
19h
MedPage Today on MSNFDA OKs New Gene Therapy for Debilitating Skin ConditionPatients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ...
Abeona Therapeutics Inc.’s ABEO share price has surged by 6.60%, which has investors questioning if this is right time to ...
Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...
Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi ...
New solutions support high-precision analytics for process development, batch release, and regulatory compliance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results